HIV TYPE 1-REACTIVE CHEMOKINE-PRODUCING CD8(-NODES() AND CD4(+) CELLSEXPANDED FROM INFECTED LYMPH)

Citation
Pl. Triozzi et al., HIV TYPE 1-REACTIVE CHEMOKINE-PRODUCING CD8(-NODES() AND CD4(+) CELLSEXPANDED FROM INFECTED LYMPH), AIDS research and human retroviruses, 14(8), 1998, pp. 643-649
Citations number
28
Categorie Soggetti
Immunology,"Infectious Diseases",Virology
ISSN journal
08892229
Volume
14
Issue
8
Year of publication
1998
Pages
643 - 649
Database
ISI
SICI code
0889-2229(1998)14:8<643:HT1CCA>2.0.ZU;2-#
Abstract
The chemokines RANTES, MIP-1 alpha, and MIP-1 beta have been identifie d as HIV-1-suppressive factors produced by CD8(+) T cells, We examined the possibility that HIV-1-specific, chemokine-releasing T cells coul d be expanded from the lymph nodes of patients with advanced infection . Lymphocytes, separated from lymph nodes of patients with peripheral blood CD4 counts less than 500/mu l obtained at diagnostic biopsies, w ere activated with anti-CD3 monoclonal antibody, and cultured in vitro for up to 12 days with IL-2, The phenotype, proliferative response, c hemokine production, and anti-HIV-1 activity of the expanded cells was examined. Cells expanded 2,4- to 49-fold from patients with as few as 15 CD4(+) cells/mu l in their peripheral blood, Expanded cells were a mixture of CD8(+)CD45RO(+) acid CD4(+)CD45RO(+) T cells, The CD8(+) c ells were also CD30(+)CDw60(+)CD11b(-). When challenged with autologou s B cell targets expressing HIV-1 Env protein, unseparated expanded ce lls, and purified CD8(+) and CD4(+) T cell subsets, proliferated and s ecreted MIP-1 alpha and RANTES, Expanded cells were negative for HIV-1 by PCR and by culture, Culture supernatants inhibited the replication of HIV-1 in CD4(+) cells in vitro, These studies indicate that HIV-1 can stimulate chemokine release by CD8(+) and CD4(+) cells expanded fr om infected lymph nodes, even from individuals with advanced infection . The numbers of chemokine-releasing T cells produced in these short-t erm cultures may be sufficient to be applied therapeutically as an aut ologous cellular therapy for HIV-1.